Sphere ENT

Forecast & Rating13 analysts currently cover Sphere ENT, with about 84.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $177.00, about 59.7% upside from the current price of $110.80. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 38.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Sphere ENT closely still see room for the stock to rise. Data as of Oct 5, 2026; for reference only and not investment advice.